Dimethyl sulphoxide does not contribute to renal failure in patients undergoing stem cell transplant for multiple myeloma and primary amyloidosis

Blood Transfus. 2012 Jan;10(1):104-5. doi: 10.2450/2011.0077-10. Epub 2011 Sep 22.
No abstract available

Publication types

  • Letter

MeSH terms

  • Amyloidosis / physiopathology*
  • Amyloidosis / therapy
  • Dimethyl Sulfoxide / administration & dosage
  • Dimethyl Sulfoxide / adverse effects*
  • Female
  • Humans
  • Kidney Function Tests
  • Male
  • Multiple Myeloma / physiopathology
  • Multiple Myeloma / therapy*
  • Renal Insufficiency / etiology*
  • Renal Insufficiency / physiopathology*
  • Retrospective Studies
  • Stem Cell Transplantation*
  • Transplantation, Homologous

Substances

  • Dimethyl Sulfoxide